Recent Posts

EU, Facebook planning high-level contacts in wake of data scandal

Bloomberg Facebook Inc. expressed a “willingness to engage” with European Union regulators in the wake of fresh evidence showing that data on most of the social network’s 2 billion users could have been accessed improperly. Justice Commissioner Vera Jourova is in touch with Facebook “to arrange for high-level contacts in the coming days,” her spokesman Christian Wigand told reporters at ...

Read More »

After $1 million drug flop, UniQure revives in gene therapy

Bloomberg UniQure NV is getting a second chance. The Dutch biotech company is angling for a comeback in gene therapy after Glybera—its groundbreaking, $1 million treatment for a rare condition—fizzled in 2017. Now UniQure is shifting the technology to the more-promising market for hemophilia, its once-battered shares have rallied back, and the company may be a takeover target. Heightened attention ...

Read More »

Uber hires from YouGov, Acromas for its UK board

Bloomberg Uber Technologies Inc is appointing two new independent non-executive directors to its UK board as it continues its bid to shore up its reputation in one of its major markets. Susan Hooper was previously head of the travel division at Acromas Group, while Roger Parry is non-executive chairman of software company Oxford Metrics and polling company YouGov Plc. The ...

Read More »
Send this to a friend